Kroslak M, et al. - In this prospective, randomized, double-blinded, placebo-controlled clinical trial, researchers assessed the utility of counterforce bracing in comparison to placebo bracing in the management of acute tennis elbow among the candidates similar in hand dominance, duration of symptoms, age, and sex. They observed a similar extent of improvement in both braces related to patient-rated pain frequency and severity, difficulty with picking up objects and twisting motions, and overall elbow function at 6 months and 3 years. They also noticed a similar level of improvement in lateral epicondyle tenderness, grip strength, and modified ORI-TETS (Orthopaedic Research Institute–Tennis Elbow Testing System) force at 6 months. But, significant variations were recognized for the frequency of pain at rest (at 6 and 12 weeks), level of pain at rest (at 2 weeks), and patient-rated overall elbow function (at 26 weeks). They preferred the counterforce brace as it afforded a significant decline in incidence and sharpness of pain in the short term (2-12 weeks), and overall elbow function at 26 weeks too.